Business
Ionis to present at 44th Annual J.P. Morgan Healthcare Conference
CARLSBAD, Calif., January 06, 2026--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will...
About this update from Ionis Pharmaceuticals, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/2c1103f43ab884b0456e31406524c55f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Uinx0Y9fGQG6Y4uVTnrzxg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/2c1103f43ab884b0456e31406524c55f","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/t1lIVv68pelT.XTXCz8Vng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/2c1103f43ab884b0456e31406524c55f","width":1024,"height":512}},"lazy":false},{"type":"text","content":"CARLSBAD, Calif., January 06, 2026--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference at 8:15 a.m. PT on Tuesday, January 13, 2026.","length":295,"tagName":"p"},{"type":"text","content":"A live webcast of the presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.","length":245,"tagName":"p"},{"type":"text","content":"About Ionis Pharmaceuticals, Inc.","length":33,"tagName":"p"},{"type":"text","content":"For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.","length":667,"tagName":"p"},{"type":"text","content":"View source version on businesswire.com: https://www.businesswire.com/news/home/20260106304033/en/","length":98,"tagName":"p"},{"type":"text","content":"Contacts",...